Orsik-E 250 mg Tablet 10's

Orsik-E 250 mg Tablet belongs to the class of antihemorrhagic drugs. It is indicated in the treatment of small vessel haemorrhage menorrhagia (menstrual bleeding that lasts more than 7 days) including IUD users and prophylaxis of periventricular haemorrhage in neonates. It prevents and controls bleeding from small blood vessels and neonatal intraventricular haemorrhage. Besides this, Orsik-E 250 mg Tablet can prevent periventricular haemorrhages in prematurely born children.

Orsik-E 250 mg Tablet contains Etamsylate, a hemostatic agent that improves platelet adhesion by restoring capillary resistance and improving platelet adhesion. On the other hand, this medicine also inhibits the biosynthesis and action of prostaglandin. These effects help to decrease abnormal bleeding.

Orsik-E 250 mg Tablet should be used as prescribed by the physician. Orsik-E 250 mg Tablet may cause side effects such as headache, skin rash, nausea and low blood pressure. These side effects are short and may go away with time; however, if they continue, consult a doctor.

Inform your doctor if you are allergic to any medications and foods, if you have acute porphyria, fever, non-cancerous growths or blood pigment disorder, or if you are pregnant or breastfeeding. Orsik-E 250 mg Tablet is not recommended to use before the onset of bleeding during periods, so inform your doctor about your condition. And also, notify your doctor about your current list of medications, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.) in order to rule out any potential negative effects.

Orsik-E 250 mg Tablet is used in the treatment of Bleeding disorders (preventing and controlling‚ bleeding from small blood vessels haemorrhage menorrhagia, neonatal intraventricular and periventricular haemorrhages). The detailed uses of Orsik-E 250 mg Tablet are as follows:

• Menorrhagia (Heavy Menstrual Bleeding): Orsik-E 250 mg Tablet reduces excessive bleeding during periods, especially in women with intrauterine devices (IUDs).
• Dysfunctional Uterine Bleeding: Orsik-E 250 mg Tablet helps manage irregular or prolonged bleeding unrelated to normal menstrual cycles.
• Surgical Bleeding: Orsik-E 250 mg Tablet is used before, during, or after delicate surgeries to minimize blood loss.
• Neonatal Hemorrhage: Orsik-E 250 mg Tablet prevents or controls bleeding in premature infants, especially intraventricular or periventricular hemorrhages.
• Spotting Between Periods: Orsik-E 250 mg Tablet treats unexpected bleeding between menstrual cycles.

• Take Orsik-E 250 mg Tablet with or without food as advised by your doctor.
• Follow your doctor's instructions on the dosage and timing of this medication to ensure safe and effective use.
• Swallow Orsik-E 250 mg Tablet as a whole with a glass of water.
• Do not crush, break, or chew it.

Orsik-E 250 mg Tablet contains Etamsylate, a hemostatic agent that improves platelet adhesion by restoring capillary resistance and improving platelet adhesion. On the other hand, Orsik-E 250 mg Tablet also inhibits the biosynthesis and action of the prostaglandin. These effects help to decrease abnormal bleeding. Thus it treats, controls, and improves various disease conditions and symptoms.

Before prescribing the Orsik-E 250 mg Tablet , let your doctor know if you are allergic to any medications and foods if you have acute porphyria, bronchial asthma, fever, non-cancerous growths or blood pigment disorder, or if you are pregnant or breastfeeding a baby. Orsik-E 250 mg Tablet is recommended not to use before the onset of bleeding during periods, so inform your doctor about your condition. And also, inform your doctor about your current list of medications (including vitamins and supplements), pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.) in order to rule out any potential negative effects.